Puns unavoidable as Avigra extends reach with TV thrust

  • Advertising
  • August 17, 2012
  • Ben Fahy
Puns unavoidable as Avigra extends reach with TV thrust

The profitability of Big Pharma's brands can collapse suddenly when patents expire and generic ‘knock offs’ flood the market. When this happens, the accepted norm is for up to 90 percent of an originator brand’s volume and share to be lost almost overnight and it’s an issue the industry hasn't yet been able to resolve, so, typically, blockbuster compounds and their brands are simply written off or retired. But the local Pfizer branch wasn't going to take the early patent expiry of Viagra in New Zealand lying down, so to speak, so it decided to launch its own generic brand called Avigra and try to migrate consumers to the cheaper, Pfizer-made alternative. And now, after a successful pun-laden press campaign and a bit of TV masthead activity, it's stiffened its resolve by creating a new TVC. 


In a sense, the idea to create Avigra was attacking its own big poppa brand, so it was a major risk, particularly because Pfizer still holds the patent for Viagra in other global markets. But this world-first has been a massive success, with Avigra establishing itself as the New Zealand ED market volume and revenue leader within nine months of launch.  

bcg2 Health's general manager Stuart Ogden says this new Avigra brand TVC builds on the magazine and newspaper consumer campaign using bold typography and topical headlines to raise awareness that it’s okay to talk to your GP about ED and deepen the understanding of the relationship between Avigra and Viagra for a wider audience than Viagra previously targeted.


“Avigra is unique to the New Zealand market, although this launch has attracted a lot of interest within the Pfizer global network," says Ogden. "This new TVC builds on the current campaign to demonstrate that Avigra = Viagra, and that it’s a more affordable option for the wide range of men who may need it."

The campaign, which has recently referenced the Olympics and even the Bluff Oyster Festival, has already won a Bronze Marketing Association RSVP award and the ‘Supplier of the Year, Best Marketing Campaign’ award at the NZ Pharmacy Awards. 


Agency - bcg2 Health, Creative Directors – James Blackwood and Robin Powell, Art Director – Mike Knight,  Account Service – Stuart Ogden and Caroline Dunlea

Digital Production – Toybox, Director: Andrew Newland, Producer: James Hudson 

Client - Phil Morcombe, Pfizer New Zealand

This is a community discussion forum. Comment is free but please respect our rules:

  1. Don’t be abusive or use sweary type words
  2. Don’t break the law: libel, slander and defamatory comments are forbidden
  3. Don’t resort to name-calling, mean-spiritedness, or slagging off
  4. Don’t pretend to be someone else.

If we find you doing these things, your comments will be edited without recourse and you may be asked to go away and reconsider your actions.
We respect the right to free speech and anonymous comments. Don’t abuse the privilege.

The case for collaboration: Garage Project talks partnerships from production to promotion

  • advertsing
  • September 20, 2019
  • Courtney Devereux
The case for collaboration: Garage Project talks partnerships from production to promotion

Collaborations provide more than just a new product, it provides an opportunity for two brands to leverage each other's audiences and learn new ways of promoting. We spoke with Pete Gillespie, co-founder of Garage Project as to why he thinks partnerships are key to keeping the energy alive when creating new campaigns.

Read more
Next page
Results for

StopPress provides essential industry news and intelligence, updated daily. And the digital newsletter delivers the latest news to your inbox twice a week — for free!

©2009–2019 ICG Media. All rights reserved.
Use of this site constitutes acceptance of our Privacy policy.


Contact Vernene Medcalf at +64 21 628 200 to advertise in StopPress.

View Media Kit